04:41 PM EDT, 04/17/2024 (MT Newswires) -- Dana Pizzuti, Chief Medical and Development Officer, on April 15, 2024, sold 14,375 shares in Crinetics Pharmaceuticals ( CRNX ) for $639,256. Following the Form 4 filing with the SEC, Pizzuti has control over a total of 27,786 shares of the company, with 27,786 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000095017024045142/xslF345X03/ownership.xml